1 :

Set-up and conduct epidemiological and baseline studies in the field of HIV/AIDS, TB, malaria, NTDs and COVID-19 necessary for future clinical trials.

2 :

Prepare the sites for future Phase I to IV clinical studies, by specifically strengthening pharmacovigilance including regulatory authorities and national or institutional ethics committees.

3 :

Design and implement training activities necessary to conduct cinical studies on traditional medicines for parasite and viral infections.

4 :

To develop and strengthen training platform and mentorship programmes for increasing skilled human resources in Central Africa including more female scientists.